GlassScriptPhysician profile
Roshan K Mathew
NPI 1093820953
$7,307.65
in general payments reported to CMS, 2019-2025
39 companies · $665 in 2025
The $665 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,726 · 2020: $1,210 · 2021: $1,051 · 2022: $1,345 · 2023: $509 · 2024: $800 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,139.59 | 2019-2024 | Xarelto |
| Amgen INC. | $806.96 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $755.82 | 2019-2024 | |
| Pfizer INC. | $477.90 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $462.45 | 2019-2024 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $369.58 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $326.94 | 2020-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $299.04 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $243.53 | 2021-2025 | Verquvo, Capvaxive |
| Terumo Medical Corporation | $215.80 | 2020-2024 | R2p Misago, Metacross Otw |
| Abbott Laboratories | $196.60 | 2020-2025 | Jot Dx, Cardiomems |
| Biotronik INC. | $185.79 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.64 | 2019-2024 | Jardiance |
| Medtronic Vascular, INC. | $139.06 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.63 | 2019-2024 | Lifevest |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $128.52 | 2020-2023 | Nexletol |
| Chiesi USA, INC. | $121.96 | 2019-2020 | |
| Boston Scientific Corporation | $118.71 | 2019-2025 | Watchman Access System, Cds - Mct/Cem Monitoring, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $112.81 | 2019-2022 | |
| Cardiovascular Systems INC. | $111.36 | 2020-2021 | |
| Philips North America LLC | $97.14 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, Mcot |
| Alnylam Pharmaceuticals INC. | $84.74 | 2019-2025 | Onpattro |
| Irhythm Technologies, INC. | $73.12 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $66.12 | 2024-2025 | Venaseal |
| Cardinal Health 200 LLC | $65.91 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $58.66 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.83 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $44.32 | 2023-2024 | Inpefa |
| Arbor Pharmaceuticals, INC. | $42.38 | 2019-2020 | |
| Abiomed | $40.94 | 2025 | |
| Lundbeck LLC | $40.19 | 2019-2020 | |
| Teleflex LLC | $22.91 | 2025 | Supercross |
| Shockwave Medical, INC | $22.78 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inspire Medical Systems, INC. | $17.10 | 2024 | Inspire |
| Vital Connect, INC | $17.04 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $16.08 | 2021 | |
| Heartflow, INC. | $14.75 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $14.72 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshan Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.